Dosing Accuracy with a Novel Pen Device (SoloSTAR ® ) as Performed by Patients with Diabetes in a Clinical Setting

The SoloSTAR pen allows people with diabetes to achieve a dosing accuracy with glargine and glulisine similar to that achieved in laboratory conditions. The dosing accuracy and ease of use of SoloSTAR may provide greater confidence in the precision and accuracy of the device while titrating glargine and/or glulisine to goal.